In a prospective BMJ Open cohort study of 1,421 adults with Type 2 Diabetes (T2DM), poorer baseline sleep quality predicted higher fasting glucose over 3.92 years and 52,940 measurements: each 1-point PSQI increase was tied to a 0.096 mmol/L rise in fasting glucose, and poor sleepers had 1.61-fold higher odds of fasting glucose ≥7.0 mmol/L. The study also linked worse sleep to greater glycaemic variability and higher odds of landing in less favourable long-term glucose trajectories — a frontline clue NPs and PAs are uniquely positioned to catch early.

Why It Matters To Your Practice

• Sleep quality is a practical, non-invasive risk marker you can spot during routine diabetes follow-up.

• Patients with worse sleep were more likely to show persistently worse glucose patterns over time, not just a one-off elevated reading.

• The signal was stronger in people with HbA1c ≥7.0% and in those with insufficient physical activity — exactly the patients you often identify first in real-world care.

Clinical Benefits

• Adding a quick sleep screen can help you identify patients at risk for suboptimal glycaemic control before trends become harder to reverse.

• PSQI-based assessment may help guide more tailored counselling on sleep, exercise, and self-management.

• Your role here is primary, not peripheral: NPs and PAs often have the continuity, trust, and practical workflow awareness needed to connect sleep symptoms with diabetes control.

Managing Risks

• This was an observational cohort study, so it shows association, not proof that poor sleep directly causes worse glycaemia.

• Sleep quality was measured only at baseline, which may not capture changes over time.

• The study relied on repeated fasting blood glucose rather than repeated HbA1c, so long-term glycaemic exposure was not measured in every possible way.

The Bottom Line

• Poor sleep may be an early warning sign for higher fasting glucose, greater variability, and less favourable long-term control in adults with T2DM.

• For NPs and PAs on the front line, that means sleep is not a soft symptom — it is actionable clinical intelligence.

• Asking about sleep may help you surface risk earlier and sharpen diabetes management for the patients who need your judgment most.